DE BERNARD, MARINA
 Distribuzione geografica
Continente #
NA - Nord America 7.447
EU - Europa 1.005
AS - Asia 466
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
AF - Africa 1
SA - Sud America 1
Totale 8.924
Nazione #
US - Stati Uniti d'America 7.330
CN - Cina 412
IT - Italia 258
DE - Germania 214
GB - Regno Unito 193
FI - Finlandia 145
CA - Canada 117
SE - Svezia 97
UA - Ucraina 73
VN - Vietnam 32
IN - India 11
ES - Italia 7
IE - Irlanda 7
JP - Giappone 5
PL - Polonia 4
AU - Australia 2
EU - Europa 2
HK - Hong Kong 2
NL - Olanda 2
BG - Bulgaria 1
BR - Brasile 1
DZ - Algeria 1
FR - Francia 1
GR - Grecia 1
IR - Iran 1
JO - Giordania 1
KZ - Kazakistan 1
NO - Norvegia 1
PT - Portogallo 1
TR - Turchia 1
Totale 8.924
Città #
Fairfield 1.187
Woodbridge 748
Ashburn 701
Chandler 700
Ann Arbor 546
Houston 493
Seattle 413
Jacksonville 392
Cambridge 385
Wilmington 382
Princeton 174
Padova 156
San Diego 125
Munich 121
Beijing 111
Mcallen 109
Montréal 109
Des Moines 98
Roxbury 76
Nanjing 74
Helsinki 51
Medford 46
Boardman 40
Dong Ket 32
Shenyang 30
New York 29
Hebei 24
Norwalk 21
Nanchang 19
Changsha 17
Jinan 16
Hefei 14
Jiaxing 14
Kunming 13
London 13
Guangzhou 11
Falls Church 10
Tianjin 10
Dublin 7
Milan 7
Hounslow 6
Arzignano 5
Borås 5
Indiana 5
Kharkiv 5
Kilburn 5
Ogden 5
Phoenix 5
Rockville 5
Shanghai 5
Washington 5
Agordo 4
Gdansk 4
Hangzhou 4
Islington 4
Ottawa 4
Redwood City 4
Valencia 4
Venice 4
Zhengzhou 4
Buffalo 3
Detroit 3
Fuzhou 3
Haikou 3
Legnaro 3
Los Angeles 3
Ningbo 3
Taizhou 3
Tappahannock 3
Acton 2
Augusta 2
Chengdu 2
Chicago 2
Chongqing 2
Cinisello Balsamo 2
Columbus 2
Council Bluffs 2
Genoa 2
Groningen 2
Hanover 2
Hong Kong 2
Matsudo 2
Mestre 2
Modena 2
New Bedfont 2
Newmarket 2
Pioltello 2
Prescot 2
Rome 2
Tokyo 2
Wuhan 2
Algiers 1
Almaty 1
Amman 1
Anaheim 1
Antalya 1
Athens 1
Baotou 1
Bassano del Grappa 1
Brescia 1
Totale 7.696
Nome #
Simulating Inflammation in a Wound Microenvironment Using a Dermal Wound-on-a-Chip Model 556
Helicobacter pylori vacuolating cytotoxin: cell intoxication and anion-specific channel activity 355
A pH-sensitive stearoyl-PEG-poly(methacryloyl sulfadimethoxine)-decorated liposome system for protein delivery: an application for bladder cancer treatment 181
Tumor-associated macrophages as major source of APRIL in gastric MALT lymphoma. 166
Autoimmune gastritis: histology phenotype and OLGA staging. 149
Supercritical carbon dioxide combined with high power ultrasound as innovate drying process for chicken breast 134
vOX2 glycoprotein of human herpesvirus 8 modulates human primary macrophages activity 132
The Helicobacter pylori VacA cytotoxin activates RBL-2H3 cells by inducing cytosolic calcium oscillations 130
The lipoprotein HP1454 of Helicobacter pylori regulates T-cell response by shaping T-cell receptor signalling 128
A Helicobacter pylori vacuolating toxin mutant that fails to oligomerize has a dominant negative phenotype 119
The immune receptor CD300e negatively regulates T cell activation by impairing the STAT1-dependent antigen presentation 119
TpF1 from Treponema pallidum Activates Inflammasome and Promotes the Development of Regulatory T Cells 117
Toll-like receptors hit calcium. 116
Helicobacter pylori-derived neutrophil-activating protein increases the lifespan of monocytes and neutrophils 111
The neutrophil-activating protein of Helicobacter pylori crosses endothelia to promote neutrophil adhesion in vivo 111
Helicobacter pylori, asthma and allergy 110
Structure and immunomodulatory property relationship in NapA of Borrelia burgdorferi 109
HP-NAP inhibits the growth of bladder cancer in mice by activating a cytotoxic Th1 response. 108
3D imaging of the 58 kDa cell binding subunit of the Helicobacter pylori cytotoxin 107
The Vibrio cholerae cytolysin promotes chloride secretion from intact human intestinal mucosa. 107
The Vibrio cholerae cytolysin promotes activation of mast cell (T helper 2) cytokine production 105
Glibenclamide stimulates fluid secretion in rodent cholangiocytes through a cystic fibrosis transmembrane conductance regulator-independent mechanism. 104
Let-7c down-regulation in Helicobacter pylori-related gastric carcinogenesis 104
The multiple cellular activities of the VacA cytotoxin of Helicobacter pylori 103
Borrelia burgdorferi NapA-Driven Th17 Cell Inflammation in Lyme Arthritis 102
Endosome-mitochondria juxtaposition during apoptosis induced by H. pylori VacA. 101
The concerted action of the Helicobacter pylori cytotoxin VacA and of the v-ATPase proton pump induces swelling of isolated endosomes 101
HP-NAP new therapy for bladder cancer: numquam periculum sine periculo vincitur 101
The Helicobacter cinaedi antigen CAIP participates in atherosclerotic inflammation by promoting the differentiation of macrophages in foam cells 101
Helicobacter pylori affects the antigen presentation activity of macrophages modulating the expression of the immune receptor CD300E through miR-4270 101
Reply to letter by Nardelli and Schell commenting on the pathogenesis of Lyme arthritis 100
Triggering of Inflammasome by Aggregated α–Synuclein, an Inflammatory Response in Synucleinopathies 100
Cytokine BAFF Released by Helicobacter pylori-Infected Macrophages Triggers the Th17 Response in Human Chronic Gastritis. 98
MicroRNA expression profiling in human Barrett's carcinogenesis. 98
The Neutrophil activating protein of Helicobacter pylori promotes T helper type 1 immune responses 95
Cell vacuolization induced by Helicobacter pylori: Inhibition by bafilomycins A1, B1, C1 and D 95
Treponema pallidum (syphilis) antigen TpF1 induces angiogenesis through the activation of the IL-8 pathway 95
Cell vacuolization induced by Helicobacter pylori VacA cytotoxin does not depend on late endosomal SNAREs 94
Bacterial toxins with intracellular protease activity 94
The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a potent stimulant of mast cells 91
Helicobacter pylori Dampens HLA-II Expression on Macrophages via the Up-Regulation of miRNAs Targeting CIITA 91
[Therapy for non-muscle invasive bladder cancer: HP-NAP.] 90
Oxidative DNA damage in gastric cancer: CagA status and OGG1 gene polymorphism. 89
Cell vacuolization induced by Helicobacter pylori VacA toxin: cell line sensitivity and quantitative estimation 88
The effect of Helicobacter pylori on asthma and allergy 88
CELLULAR VACUOLES INDUCED BY HELICOBACTER-PYLORI ORIGINATE FROM LATE ENDOSOMAL COMPARTMENTS 85
Evaluation of the efficacy of the H. Pylori protein HP-NAP as a therapeutic tool for treatment of bladder cancer in an orthotopic murine model 85
Virulence factors of Helicobacter pylori 83
Cerebrospinal fluid T-regulatory cells recognize Borrelia burgdorferi NAPA in chronic Lyme borreliosis. 83
Stimulation of TH1 response by Helicobacter pylori neutrophil activating protein decreases the protective role of IgE and eosinophils in experimental trichinellosis. 82
The neutrophil-activating protein of Helicobacter pylori down-modulates Th2 inflammation in ovalbumin-induced allergic asthma 81
Inhibition of intracellular cholesterol transport alters presenilin localization and amyloid precursor protein processing in neuronal cells 80
Characterisation of a monoclonal antibody and its use to purify the cytotoxin of Helicobacter pylori 80
Chlamydophila pneumoniae phospholipase D (CpPLD) drives Th17 inflammation in human atherosclerosis 79
BAFILOMYCIN-A1 INHIBITS HELICOBACTER-PYLORI-INDUCED VACUOLIZATION OF HELA-CELLS 79
Molecular and cellular mechanisms of action of the vacuolating cytotoxin (VacA) and neutrophil-activating protein (HP-NAP) virulence factors of Helicobacter pylori 77
The vacuolar ATPase proton pump is present on intracellular vacuoles induced by Helicobacter pylori 76
The immune modulating activity of the Helicobacter pylori HP-NAP: Friend or foe? 75
Helicobacter pylori toxin VacA induces vacuole formation by acting in the cell cytosol 75
The m2 form of the Helicobacter pylori cytotoxin has cell type-specific vacuolating activity 75
Supercritical CO2 drying of food matrices 73
Tumor Cells and the Extracellular Matrix Dictate the Pro-Tumoral Profile of Macrophages in CRC 71
The small GTP binding protein rab7 is essential for cellular vacuolation induced by Helicobacter pylori cytotoxin 69
the VacA toxin of Helicobacter pylori identifies a new intermediate filament-interacting protein 68
IFN-gamma and R-848 dependent activation of human monocyte-derived dendritic cells by Neisseria meningitidis adhesin A. 67
Helicobacter pylori HP0175 promotes the production of IL-23, IL-6, IL-1 beta and TGF-beta 66
Helicobacter pylori vacuolating toxin forms anion-selective channels in planar lipid bilayers: Possible implications for the mechanism of cellular vacuolation 66
Selective increase of the permeability of polarized epithelial cell monolayers by Helicobacter pylori vacuolating toxin 64
An intracellular target for Helicobacter pylori vacuolating toxin - Response from de Bernard and Arico 60
Orchestration of inflammation and adaptive immunity in Borrelia burgdorferi-induced arthritis by NapA 60
VacA and HP-NAP Ying and Yang of Helicobacter pylori-associated gastric inflammation 59
Helicobacter pylori antigenic Lpp20 is a structural homologue of Tipα and promotes epithelial-mesenchymal transition 59
Action site and cellular effects of cytotoxin VacA produced by Helicobacter pylori 57
The Vibrio choleare haemolysin anion channel is required for cell vacuolation and death 56
Immunosuppression of T(H)2 responses in Trichinelia spiralis infection by Helicobacter pylori neutrophil-activating protein 56
Molecular and Cellular Mechanisms of action of the VacA and HP-NAP virulence factors 54
The neutrophil-activating protein of Helicobacter pylori (HP-NAP) as an immune modulating agent 53
BAFfling autoimmune disorders and helicobacter pylori disease: The interplay between BAFF and the Th17 response 53
Identification of Bacterial Factors Able to Promote a Th17 Response in Gastric Mucosa of H. pylori-Infected Patients 52
HELICOBACTER-PYLORI CYTOTOXIN - IMPORTANCE OF NATIVE CONFORMATION FOR INDUCTION OF NEUTRALIZING ANTIBODIES 52
The C2 fragment from Neisseria meningitidis antigen NHBA increases endothelial permeability by destabilizing adherens junctions. 50
The acid activation of Helicobacter pylori toxin VacA: Structural and membrane binding studies 50
Identification of the Helicobacter pylori VacA toxin domain active in the cell cytosol 49
Macrophage-Mediated Melanoma Reduction after HP-NAP Treatment in a Zebrafish Xenograft Model 49
Pathogenesis of Helicobacter pylori infection. 46
Molecular and cellular activities of Helicobacter pylori pathogenic factors 45
Supercritical CO2 drying of food matrices 45
pH responsive liposomes for enhanced local protein delivery to cancer tissues. 44
The Vibrio cholerae cytolysin (VCC) promotes intestinal chloride secretion and TH2 cytokines production by mucosal mast cells 44
Evaluation of the ability of Helicobacter pylori in inducing the production of B cells activating factors: possible implications in the development of MALT lymphomas 43
ADP-heptose enables Helicobacter pylori to exploit macrophages as a survival niche by suppressing antigen-presenting HLA-II expression 43
Immunosoppressive and Proinflammatory Activities of the VacA Toxin of Helicobacter pylori 42
Chloride secretion in intact human colon induced by the Vibrio cholerae cytolysin 42
Helicobacter pylori vacuolating cytotoxin and neutrophil activating protein 41
Molecular and cellular mechanisms of action of the VacA and HP-NAP virulence factors of Helicobacter pylori 40
Low pH Activates the Vacuolating Toxin of Helicobacter Pylori which Becomes Acid and Pepsin Resistant 40
INVOLVEMENT AND SOURCE OF B-CELLS ACTIVATING FACTOR(S) IN H. PYLORI-ASSOCIATED DISEASES 38
Helicobacter pylori vacuolating cytotoxin and associated pathogenic factors 38
Bacterial toxin: intracellular trafficking and target identification. 36
The Vibrio cholerae cytolysin promotes intestinal chloride secretion in Human colon 35
Totale 8.864
Categoria #
all - tutte 29.295
article - articoli 27.330
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 632
Totale 57.257


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019766 0 0 0 0 0 0 0 0 0 171 314 281
2019/20202.116 295 100 82 216 233 160 242 215 182 213 102 76
2020/20211.432 49 96 35 88 210 68 14 171 202 162 189 148
2021/20221.524 51 184 178 117 62 103 76 170 73 30 159 321
2022/20231.265 236 165 50 146 178 194 1 83 144 9 46 13
2023/2024696 31 94 83 51 39 61 25 262 25 25 0 0
Totale 9.153